Page last updated: 2024-10-28

hexamethonium and Disease

hexamethonium has been researched along with Disease in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RAFSKY, HA1
HORONICK, A1
RAFSKY, JC1
PHELAN, EL1
ERYETISHIR, I1
SMIRK, FH1

Other Studies

2 other studies available for hexamethonium and Disease

ArticleYear
Treatment of hypertension in elderly patients with methium chloride; preliminary report.
    Journal of the American Geriatrics Society, 1953, Volume: 1, Issue:8

    Topics: Aged; Cardiovascular Agents; Disease; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central

1953
Observations on the responses of rats with spontaneous hypertension and control rats to pressor drugs and to hexamethonium.
    Circulation research, 1962, Volume: 10

    Topics: Arginine Vasopressin; Disease; Epinephrine; Hexamethonium; Hypertension; Rats; Rodent Diseases; Thio

1962